Gilead Sciences
Clinical trials sponsored by Gilead Sciences, explained in plain language.
-
New hope for tough-to-treat colon cancer? drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called denikitug, alone or with other medicines, in people with advanced colorectal cancer that is microsatellite stable (MSS), a type that often doesn't respond to immunotherapy. About 170 participants will be randomly assigned to different treatment …
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo aims to shrink hard-to-treat stomach cancers
Disease control Not yet recruitingThis study tests a new drug called denikitug, alone or with other treatments, in people with advanced HER2-negative stomach, gastroesophageal junction, or esophageal cancer that has spread or come back after initial therapy. About 120 participants will be randomly assigned to rec…
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 11, 2026 20:52 UTC